Sunday, December 18, 2011

Sanofi-Aventis Seeking Suitor For US Dermatology Business

Sanofi-Aventis SA (NYSE:SNY), France's largest drug maker, is seeking a buyer for its US dermatology business in a sale that could fetch as much as 3 million, according to a Bloomberg Businessweek report. First-round bids were submitted last week, according to two unnamed sources with knowledge of the matter, who declined to be identified because the talks are private. Deutsche Bank AG is handling the sale for Sanofi, they said. Sanofi completed its acquisition of Cambridge, Massachusetts based Genzyme Corp, the world's largest maker of medicines for rare genetic disorders, for at least .1 billion. "Sanofi-Aventis US is exploring strategic alternatives for the US dermatology business in keeping with its strategy to reallocate resources to high-growth areas including diabetes, oncology, and atrial fibrillation," Sanofi said in an e-mailed statement yesterday. Private-equity firms are the most likely suitors for the dermatology business. The valuation has been hurt because competitors have introduced generic versions of one of its products, Benzaclin topical acne treatment, one person said.

Clothes Dryer Buy Promotion Gas Cans Spouts Olympus Evolt 500 Buy

Saturday, December 10, 2011

Benzaclin Review

FOLLOW ME! :] jennymitsuko.blogspot.com jennymitsuko.blogspot.com jennymitsuko.blogspot.com I'm sorry I'm scatter brained and I don't plan out my videos. Guess I should start doing that. Got this with a prescription from my doctor, since even mild acne qualifies as "ugly" with my mama.

Shop Black And Decker Buffer Ti 83 Scientific Calculator Online Save You Money! Low Cost Toro 1800 Snow Blower


Twitter Facebook Flickr RSS



Fran�ais Deutsch Italiano Portugu�s
Espa�ol ??? ??? ?????







Sponsor Links